Document ID: chunk:federal_register_of_legislation:F2013C00288:reg:14:p4
Version: federal_register_of_legislation:F2013C00288
Segment Type: reg
Provision Reference: reg 14 (pt 4/4)
Character Range: 884207–885712

Blood lead modelling
4.8.2 Bioavailability and bioaccessibility
4.8.3 The approach for petroleum hydrocarbons
5 Toxicity assessment
5.1 Introduction
5.1.1 Sources of toxicity information
5.1.2 Sources of physical and chemical data
5.2 Hazard identification
5.2.1 Acute effects
5.2.2 Chronic threshold effects
5.2.3 Chronic cancer effects
5.3 Doseresponse assessment
5.3.1 Overview
5.3.2 Threshold toxicity reference values
5.3.3 Cancer toxicity reference values
5.4 Other considerations in toxicity assessment
5.4.1 Absence of information
5.4.2 Early-life susceptibility
5.4.3 Metal speciation
6 Risk Characterisation
6.1 Overview
6.2 General risk characterisation principles
6.3 Risk estimation
6.3.1 Threshold risk estimation
6.3.2 Non-threshold risk estimation
6.4 Risk evaluation
6.4.1 Threshold risk evaluation
6.4.2 Non-threshold risk evaluation  acceptable level of cancer
risk
6.5 Risk evaluation of mixtures
6.6 Uncertainty and sensitivity analysis
6.6.1 Uncertainty analysis
6.6.2 Sensitivity analysis
7 Risk communication and management
7.1 Risk communication
7.2 Risk management
8 Bibliography
9 Appendix 1: Structure of a risk assessment
report
9.1 Introduction
9.2 General
9.3 Key principles
9.3.1 Overview
9.3.2 Issues identification
9.3.3 Data collection and evaluation (development of a conceptual site model)
9.3.4 Exposure assessment
9.3.5 Toxicity assessment
9.3.6 Risk characterisation
9.3.6.1 Overview
9.3.6.2 Uncertainty
9.3.6.3 Sensitivity analysis
10 Glossary
11 Shortened forms